Published in N Engl J Med on May 29, 1975
Specific cellular immune unresponsiveness in human filariasis. Immunology (1977) 2.23
The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man. Clin Exp Immunol (1978) 1.40
Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole. Proc Natl Acad Sci U S A (1975) 0.97
Cell-mediated immunity and its role in resistance to infection. West J Med (1977) 0.85
Immunosuppressive properties of sera and urine dialysates from kidney-graft recipients treated with azathioprine, prednisolone, and niridazole. Br Med J (1977) 0.75
Effect of niridazole in cellular immunity in vivo and in vitro. Clin Exp Immunol (1978) 0.75
Studies on the pathogenesis of experimental autoimmune renal tubulointerstitial disease in guinea-pigs. IV. failure to inhibit mononuclear cell accumulation with niridazole. Clin Exp Immunol (1977) 0.75
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
A VIRUS ENCOUNTERED IN THE STUDY OF MATERIAL FROM CASES OF ENCEPHALITIS N THE ST. LOUIS AND KANSAS CITY EPIDEMICS OF 1933. Science (1933) 6.93
Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50
Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (1996) 3.63
NUTRITION OF THE HOST AND NATURAL RESISTANCE TO INFECTION : I. THE EFFECT OF DIET ON THE RESPONSE OF SEVERAL GENOTYPES OF MUS MUSCULUS TO SALMONELLA ENTERITIDIS INFECTION. J Exp Med (1945) 3.52
A chromosome bin map of 16,000 expressed sequence tag loci and distribution of genes among the three genomes of polyploid wheat. Genetics (2004) 3.37
ISOLATION OF POLIOMYELITIS VIRUS FROM THE NASOPHARYNX. J Exp Med (1935) 3.14
Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (1975) 2.92
RECOVERY OF EASTERN EQUINE ENCEPHALOMYELITIS VIRUS FROM BRAIN TISSUE OF HUMAN CASES OF ENCEPHALITIS IN MASSACHUSETTS. Science (1938) 2.88
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
ST. LOUIS ENCEPHALITIS. Science (1934) 2.80
Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59
ANTIRABIC IMMUNIZATION WITH CULTURE VIRUS RENDERED AVIRULENT BY ULTRA-VIOLET LIGHT. Science (1937) 2.59
Diagnostic and Immunological Tests of Rabies in Mice. Am J Public Health Nations Health (1936) 2.56
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol (1968) 2.18
Experiments on Antirabic Vaccination With Tissue Culture Virus. Am J Public Health Nations Health (1938) 2.13
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis (2009) 1.92
The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. Development (1997) 1.84
An Improved Non-Virulent Rabies Vaccine. Am J Public Health Nations Health (1942) 1.80
Dispersion of papers among journals based on a mathematical analysis of two diverse medical literatures. Nature (1969) 1.79
Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis (2011) 1.74
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature (1974) 1.72
Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70
CHARACTERISTICS OF A STRAIN OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS ENCOUNTERED AS A CONTAMINANT IN TISSUE CULTURES OF RABIES VIRUS. J Exp Med (1940) 1.69
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
Tropical medicine. BMJ (2000) 1.67
Cell-mediated damage to helminths. Adv Parasitol (1984) 1.64
GIANT CELLS IN CULTURES FROM HUMAN LYMPH NODES. J Exp Med (1921) 1.63
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg (1985) 1.58
MIGRATION OF LYMPHOCYTES IN PLASMA CULTURES OF HUMAN LYMPH NODES. J Exp Med (1921) 1.58
The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58
PROPAGATION OF RABIES VIRUS IN TISSUE CULTURE AND THE SUCCESSFUL USE OF CULTURE VIRUS AS AN ANTIRABIC VACCINE. Science (1936) 1.57
Granuloma formation around Schistosoma mansoni, S. HAEMATOBIUM, AND S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg (1970) 1.56
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med (1980) 1.50
Immunity to schistosomes: progress toward vaccine. Science (1987) 1.49
Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis (1973) 1.47
High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol (1998) 1.47
The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy. J Cell Sci (1978) 1.46
Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun (1993) 1.46
Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis (2009) 1.46
Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology (1999) 1.45
The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44
A functional classification of granulomatous inflammation. Ann N Y Acad Sci (1976) 1.44
An application of the Kermack-McKendrick theory to the epidemiology of schistosomiasis. Am J Trop Med Hyg (1970) 1.43
Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43
Thymus dependency of host resistance to Giardia muris infection: studies in nude mice. J Immunol (1978) 1.42
A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils. J Immunol Methods (1990) 1.42
AN IRRADIATED NON-VIRULENT ANTIRABIES VACCINE. Science (1940) 1.42
Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun (1976) 1.42
Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41
Benzoyl and hydroxybenzoyl esters of coenzyme A. Ultraviolet characterization and reaction mechanisms. J Biol Chem (1974) 1.40
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
THE USE OF ULTRAVIOLET LIGHT IN PREPARING A NON-VIRULENT ANTIRABIES VACCINE. J Exp Med (1940) 1.39
Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol (1977) 1.37
Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol (1981) 1.35
Hepatosplenic schistosomiasis mansoni: an immunologic disease. Bull N Y Acad Med (1975) 1.34
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro. J Exp Med (1983) 1.34
Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans R Soc Trop Med Hyg (2004) 1.33
Analysis of expressed sequence tag loci on wheat chromosome group 4. Genetics (2004) 1.33
A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology (1995) 1.33
The inhibition of granuloma formation around Schistosoma mansoni eggs. I. Immunosuppressive drugs. Am J Trop Med Hyg (1967) 1.33
Th ecology of the medical literatures. Am J Med Sci (1972) 1.32
Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol (1997) 1.31
Selective primary health care: an interim strategy for disease control in developing countries. Soc Sci Med Med Econ (1980) 1.31
Dynamics of antigen and mitogen-induced responses in murine schistosomiasis japonica: in vitro comparison between hepatic granulomas and splenic cells. J Immunol (1981) 1.31
Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci U S A (1997) 1.30
IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol (1993) 1.30
Immunoprecipitation of surface antigen precursors from Schistosoma mansoni messenger RNA in vitro translation products. Mol Biochem Parasitol (1984) 1.30
Chromosome bin map of expressed sequence tags in homoeologous group 1 of hexaploid wheat and homoeology with rice and Arabidopsis. Genetics (2004) 1.29
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg (1985) 1.29
Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol (1974) 1.29
The Schistosoma mansoni egg granuloma: quantitation of cell populations. J Pathol (1977) 1.29
Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain. Parasitology (1976) 1.28
Human IgE responses to Schistosoma mansoni and resistance to reinfection. Mem Inst Oswaldo Cruz (1992) 1.28
The secretion of migration inhibitory factor by intact schistosome egg granulomas maintained in vitro. Nature (1973) 1.28
Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol (1975) 1.27